Treatment Information

Back

Prostate Cancer treatment details. Biologic therapy.

Advocate Lutheran General Hospital, Park Ridge, IL, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Park Ridge, IL
Treatments:Biologic therapyHospital:Advocate Lutheran General Hospital
Drugs:Journal:Link
Date:Oct 2013

Description:

Patients:
This phase 2 study involved 21 castration-resistant prostate cancer patients who had not received prior chemotherapy. The median patient age was 74 years.

Treatment:
Patients were treated with the biologic therapy agent temsirolimus, which is an inhibitor of the mTOR protein that interferes with cancer cell growth.

Toxicities:
Death due to intracerebral bleeding and surgical complications were reported for this study, but were considered not related to treatment. Grade 3-4 fatigue, pain and pneumonia were also reported.

Results:
The median overall survival was 13 months.

Correspondence: Dr. C Nabhan; email: [email protected]



Back